stockrow
Saturday 7 November 2026
Export PPBT’s income statement to Excel — free account
Purple Biotech Ltd. Sponsored ADR
PPBT Healthcare Biotechnology
- EPS
- +110.2%
- Free cash flow
- −62.1%
Quarter to June 2026, against a year earlier
1.28
0.03
+2.40%
Follow PPBT
Alert me
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
— | — | — | — |
+8 more quarters Free account |
EV/Sales |
— | — | — | — | |
EV/FCF |
— | — | — | — | |
Quick Ratio |
3.42 | 1.40 | 1.23 | 1.73 | |
Current Ratio |
3.70 | 1.48 | 1.27 | 1.78 | |
Net Debt/EBITDA |
4.97 | 2.94 | 0.41 | 7.99 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
(5.68) | 36.29 | 0.05 | 0.82 | |
Capex/Depreciation |
(0.04) | 0.00 | (0.17) | 0.14 | |
Interest Coverage |
(144.33) | (72.61) | (24.89) | (273.40) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.52 | 0.51 | 0.42 | 0.71 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow Yield |
— | — | — | — | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(2.30) | (3.35) | (2.22) | (2.34) | |
Capex per Share |
0.00 | 0.00 | (0.02) | 0.02 | |
Free Cash Flow per Share |
(2.31) | (3.35) | (2.24) | (2.32) | |
Cash per Share |
5.62 | 6.90 | 19.94 | 22.95 | |
Shareholders Equity per Share |
11.25 | 10.38 | 20.12 | 72.04 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
11.25 | 10.38 | 20.12 | 72.04 | |
Free Cash Flow |
(2.51) | (3.12) | (1.08) | (1.06) | |
Working Capital |
4.81 | 2.19 | 2.11 | 4.72 | |
Capital Expenditures |
0.00 | — | (0.01) | 0.01 | |
Net Current Asset Value |
4.64 | 2.03 | 1.95 | 4.53 | |
EV/EBIT |
— | — | — | — | |
Capex to Sales |
0.00 | — | 0.00 | 0.00 | |
| Other line items | |||||
Average Payables |
0.58 | 0.86 | 1.76 | 1.26 | |
Average Assets |
24.27 | 25.01 | 27.31 | 37.08 | |
Average Common Equity |
22.13 | 21.18 | 21.29 | 31.14 |
Columns are period end dates · fundamentals updated 26 Oct 2026